Cost-effectiveness of Laser Doppler Imaging in Burn Care
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Accurate early burn depth assessment is important to determine the optimal treatment. The most applied method to asses burn depth is clinical assessment. This method is the least expensive, but not very accurate. Laser Doppler imaging (LDI) has been shown to accurately assess burn depth. The clinical effects, the costs and cost-effectiveness of this device however, are unknown. The hypothesis is that an eary accurate diagnosis will lead to an earlier therapeutic decision: surgery or no surgery. Earlier excision and grafting probably leads to a decrease in wound healing time, in length of hospital stay and in costs.
Before the investigators decide to implement LDI in Dutch burn care a study of the clinical effects and cost-effectiveness of LDI is necessary. Therefore a multicenter randomized controlled trial will be conducted, including all patients with burns of indeterminate depth (burns that are not obviously superficial or full thickness) treated in the Dutch burn centres. In total 200 patients will be included in an 18 months period. The patients are randomly divided in two groups: 'new diagnostic strategy' versus 'current diagnostic strategy'. Burn depth will be diagnosed both by clinical assessment and laser Doppler imaging in all patients. The results of the LDI-scan will be provided to the treating clinician in the 'new diagnostic strategy' group only. Time to wound healing, diagnostic and therapeutic decisions, and costs are observed.
| Condition | Intervention |
|---|---|
|
Burns |
Device: laser Doppler imager (Moor) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Cost-effectiveness of Laser Doppler Imaging in Burn Care in the Netherlands |
- Wound healing time [ Time Frame: 14 days post burn ] [ Designated as safety issue: No ]Time to complete wound healing (>95 % reepithelialisation) and rate of wound healing (% reepithelialisation) at day 14 post burn will be assessed clinically (Bloemen et al., 2011)
- The effect of LDI on patient outcomes: quality of life and scar quality [ Time Frame: 3 months post burn ] [ Designated as safety issue: No ]
Quality of life is measured with the EuroQol-5D in patient ≥ 5 years old (Bouillon et al., 2002) or the ItQol-47 in patients <5 years old (Raat et al., 2007):
- Baseline measurement within one month post burn
- Second measurement within 3 months post burn
Scar quality is measured after 3 months:
- Scar elasticity with the Cutometer® Skin Elasticity Meter 575 (Draaijers et al., 2004)
- Vascularity and pigmentation with the Dermaspectometer (Draaijers et al., 2004)
- Self-reported scar quality: Patients Observer Scar Assessment Scale (van der Wal et al., 2011)
- The effect of LDI on diagnostic and therapeutic decisions [ Time Frame: Until wound healing, circa 2-6 weeks ] [ Designated as safety issue: No ]
Effect of the introduction of the LDI will be assessed by comparing diagnostic decisions of burn clinicians, before and after the use of LDI.
Possible diagnostic decisions are (Monstrey et al., 2011):
- Superficial dermal burn, will heal (within 14 days)
- Intermediate burn (possible will heal, or needs grafting)
- Deep dermal or subdermal (full thickness) burn, needs grafting (will not heal within 21 days)
The possible therapeutic decisions are:
- Surgery
- Postponement of decision
- No surgery
- The effect of LDI on total (medical and non medical) costs [ Time Frame: From injury until 3 months post burn ] [ Designated as safety issue: No ]
Costs from a societal perspective are calculated (following the Dutch guidelines from Oostenbrink et al., 2004):
- Costs during hospital stay
- Outpatient costs
- Non-hospital and non-medical costs
- The cost-effectiveness of LDI compared to the standard diagnostic strategy [ Time Frame: From injury until 3 months post burn ] [ Designated as safety issue: No ]
In case of differences in patient outcome (wound healing time and scar quality) between both diagnostic strategies, cost-effectiveness will be calculated by dividing the difference in average costs by the difference in average time of wound healing or scar quality.
In case of difference in quality of life between both diagnostic strategies, cost-utility will be calculated by dividing the difference in average costs by the difference in Quality Adjusted Life Years (QALY's).
| Estimated Enrollment: | 200 |
| Study Start Date: | December 2011 |
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: new diagnostic strategy
Combination of laser Doppler imaging and clinical assessment of burn depth
|
Device: laser Doppler imager (Moor)
The laser Doppler imager measures the blood flow of the skin/burn
Other Names:
|
|
No Intervention: current diagnostic strategy
Clinical assessment of burn depth
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
- Patients with acute burns of indeterminate depth (=intermediate depth, not obviously superficial or full thickness) at presentation
- Outpatient treatment or admission in one of the three Dutch burn centres
- Presentation within 5 days post burn
Exclusion criteria
- A presence of both burns of indeterminate depth and full thickness at presentation
- Patients with peri-orbital facial burns, in which the eyes are unable to shield
- Patients or their next of kin if they are under aged or temporary incompetent who can not be expected to give informed consent e.g. because of cognitive dysfunction or poor Dutch proficiency.
- Patients with a TBSA burned > 20%
Contacts and Locations| Contact: Jenda Hop, MD | 0031 10 291 2789 | hopm@maasstadziekenhuis.nl |
| Netherlands | |
| Red Cross Hospital | Recruiting |
| Beverwijk, Noord-Holland, Netherlands, 1940 EB | |
| Contact: Martijn BA van der Wal, MD 0031 251 264917 mvdwal@rkz.nl | |
| Principal Investigator: Martijn BA van der Wal, MD | |
| Maasstad Hospital | Recruiting |
| Rotterdam, Zuid-Holland, Netherlands, 3079 DZ | |
| Contact: Jenda Hop, MD 0031 10 291 2789 hop@maasstadziekenhuis.nl | |
| Principal Investigator: Jenda Hop, MD | |
| Martini Hospital | Recruiting |
| Groningen, Netherlands, 9700 RM | |
| Contact: Marianne K Nieuwenhuis, PhD 0031 50 524 5565 m.k.nieuwenhuis@mzh.nl | |
| Principal Investigator: Marianne K Nieuwenhuis, PhD | |
| Study Chair: | Margriet E Baar, PhD | Associaton of Dutch Burns Centres |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Association of Dutch Burn Centres |
| ClinicalTrials.gov Identifier: | NCT01489540 History of Changes |
| Other Study ID Numbers: | 2011-47 |
| Study First Received: | November 30, 2011 |
| Last Updated: | February 16, 2012 |
| Health Authority: | Netherlands: Medical Ethics Review Committee (METC) |
Keywords provided by Association of Dutch Burn Centres:
|
Burn Depth Diagnosis Laser Doppler Imaging |
Additional relevant MeSH terms:
|
Burns Wounds and Injuries |
ClinicalTrials.gov processed this record on May 21, 2013